Atlas Trials

Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan

Clinical trial NCT04559581 · COMPLETED

Trial details

NCT number
NCT04559581
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
Lung Diseases, Interstitial
Start date
2020-10-02
Primary completion
2024-12-18
Enrollment
425

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.